Europe Cancer Biomarkers Market Report 2016

Publisher Name :
Date: 25-Oct-2016
No. of pages: 124
Inquire Before Buying

Notes:

Sales, means the sales volume of Cancer Biomarkers

Revenue, means the sales value of Cancer Biomarkers

This report studies sales (consumption) of Cancer Biomarkers in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

- Abbott Laboratories (U.S.)

- Affymetrix Inc. (U.S.)

- Roche Diagnostics Ltd. (Switzerland)

- Illumina, Inc. (U.S.)

- Qiagen NV (Netherlands)

- Agilent Technologies (U.S.)

- Thermo Fisher Scientific Inc. (U.S.)

- Merck & Co. Inc. (U.S.)

- Becton Dickinson and Company (U.S.)

- Hologic Inc. (U.S.)

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Cancer Biomarkers in these countries, from 2011 to 2021 (forecast), like

- Germany

- France

- UK

- Russia

- Italy

- Spain

- Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Protein Biomarkers

- Genetic Biomarkers

- Others

Split by application, this report focuses on sales, market share and growth rate of Cancer Biomarkers in each application, can be divided into

- Diagnostics

- Drug Discovery and Development

- Prognostics

- Risk Assessment

- Others?

Europe Cancer Biomarkers Market Report 2016

Table of Contents
Europe Cancer Biomarkers Market Report 2016
1 Cancer Biomarkers Overview
1.1 Product Overview and Scope of Cancer Biomarkers
1.2 Classification of Cancer Biomarkers
1.2.1 Protein Biomarkers
1.2.2 Genetic Biomarkers
1.2.3 Others
1.3 Application of Cancer Biomarkers
1.3.1 Diagnostics
1.3.2 Drug Discovery and Development
1.3.3 Prognostics
1.3.4 Risk Assessment
1.3.5 Others?
1.4 Cancer Biomarkers Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Cancer Biomarkers (2011-2021)
1.5.1 Europe Cancer Biomarkers Sales and Growth Rate (2011-2021)
1.5.2 Europe Cancer Biomarkers Revenue and Growth Rate (2011-2021)
2 Europe Cancer Biomarkers by Manufacturers, Type and Application
2.1 Europe Cancer Biomarkers Market Competition by Manufacturers
2.1.1 Europe Cancer Biomarkers Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Cancer Biomarkers Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Cancer Biomarkers (Volume and Value) by Type
2.2.1 Europe Cancer Biomarkers Sales and Market Share by Type (2011-2016)
2.2.2 Europe Cancer Biomarkers Revenue and Market Share by Type (2011-2016)
2.3 Europe Cancer Biomarkers (Volume and Value) by Countries
2.3.1 Europe Cancer Biomarkers Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Cancer Biomarkers Revenue and Market Share by Countries (2011-2016)
2.4 Europe Cancer Biomarkers (Volume) by Application
3 Germany Cancer Biomarkers (Volume, Value and Sales Price)
3.1 Germany Cancer Biomarkers Sales and Value (2011-2016)
3.1.1 Germany Cancer Biomarkers Sales and Growth Rate (2011-2016)
3.1.2 Germany Cancer Biomarkers Revenue and Growth Rate (2011-2016)
3.1.3 Germany Cancer Biomarkers Sales Price Trend (2011-2016)
3.2 Germany Cancer Biomarkers Sales and Market Share by Manufacturers
3.3 Germany Cancer Biomarkers Sales and Market Share by Type
3.4 Germany Cancer Biomarkers Sales and Market Share by Application
4 France Cancer Biomarkers (Volume, Value and Sales Price)
4.1 France Cancer Biomarkers Sales and Value (2011-2016)
4.1.1 France Cancer Biomarkers Sales and Growth Rate (2011-2016)
4.1.2 France Cancer Biomarkers Revenue and Growth Rate (2011-2016)
4.1.4 France Cancer Biomarkers Sales Price Trend (2011-2016)
4.2 France Cancer Biomarkers Sales and Market Share by Manufacturers
4.3 France Cancer Biomarkers Sales and Market Share by Type
4.4 France Cancer Biomarkers Sales and Market Share by Application
5 UK Cancer Biomarkers (Volume, Value and Sales Price)
5.1 UK Cancer Biomarkers Sales and Value (2011-2016)
5.1.1 UK Cancer Biomarkers Sales and Growth Rate (2011-2016)
5.1.2 UK Cancer Biomarkers Revenue and Growth Rate (2011-2016)
5.1.5 UK Cancer Biomarkers Sales Price Trend (2011-2016)
5.2 UK Cancer Biomarkers Sales and Market Share by Manufacturers
5.3 UK Cancer Biomarkers Sales and Market Share by Type
5.4 UK Cancer Biomarkers Sales and Market Share by Application
6 Russia Cancer Biomarkers (Volume, Value and Sales Price)
6.1 Russia Cancer Biomarkers Sales and Value (2011-2016)
6.1.1 Russia Cancer Biomarkers Sales and Growth Rate (2011-2016)
6.1.2 Russia Cancer Biomarkers Revenue and Growth Rate (2011-2016)
6.1.6 Russia Cancer Biomarkers Sales Price Trend (2011-2016)
6.2 Russia Cancer Biomarkers Sales and Market Share by Manufacturers
6.3 Russia Cancer Biomarkers Sales and Market Share by Type
6.4 Russia Cancer Biomarkers Sales and Market Share by Application
7 Italy Cancer Biomarkers (Volume, Value and Sales Price)
7.1 Italy Cancer Biomarkers Sales and Value (2011-2016)
7.1.1 Italy Cancer Biomarkers Sales and Growth Rate (2011-2016)
7.1.2 Italy Cancer Biomarkers Revenue and Growth Rate (2011-2016)
7.1.7 Italy Cancer Biomarkers Sales Price Trend (2011-2016)
7.2 Italy Cancer Biomarkers Sales and Market Share by Manufacturers
7.3 Italy Cancer Biomarkers Sales and Market Share by Type
7.4 Italy Cancer Biomarkers Sales and Market Share by Application
8 Spain Cancer Biomarkers (Volume, Value and Sales Price)
8.1 Spain Cancer Biomarkers Sales and Value (2011-2016)
8.1.1 Spain Cancer Biomarkers Sales and Growth Rate (2011-2016)
8.1.2 Spain Cancer Biomarkers Revenue and Growth Rate (2011-2016)
8.1.8 Spain Cancer Biomarkers Sales Price Trend (2011-2016)
8.2 Spain Cancer Biomarkers Sales and Market Share by Manufacturers
8.3 Spain Cancer Biomarkers Sales and Market Share by Type
8.4 Spain Cancer Biomarkers Sales and Market Share by Application
9 Benelux Cancer Biomarkers (Volume, Value and Sales Price)
9.1 Benelux Cancer Biomarkers Sales and Value (2011-2016)
9.1.1 Benelux Cancer Biomarkers Sales and Growth Rate (2011-2016)
9.1.2 Benelux Cancer Biomarkers Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Cancer Biomarkers Sales Price Trend (2011-2016)
9.2 Benelux Cancer Biomarkers Sales and Market Share by Manufacturers
9.3 Benelux Cancer Biomarkers Sales and Market Share by Type
9.4 Benelux Cancer Biomarkers Sales and Market Share by Application
10 Europe Cancer Biomarkers Manufacturers Analysis
10.1 Abbott Laboratories (U.S.)
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Cancer Biomarkers Product Type, Application and Specification
10.1.2.1 Type I
10.1.2.2 Type II
10.1.3 Abbott Laboratories (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main Business/Business Overview
10.2 Affymetrix Inc. (U.S.)
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Cancer Biomarkers Product Type, Application and Specification
10.2.2.1 Type I
10.2.2.2 Type II
10.2.3 Affymetrix Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main Business/Business Overview
10.3 Roche Diagnostics Ltd. (Switzerland)
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Cancer Biomarkers Product Type, Application and Specification
10.3.2.1 Type I
10.3.2.2 Type II
10.3.3 Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main Business/Business Overview
10.4 Illumina, Inc. (U.S.)
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Cancer Biomarkers Product Type, Application and Specification
10.4.2.1 Type I
10.4.2.2 Type II
10.4.3 Illumina, Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main Business/Business Overview
10.5 Qiagen NV (Netherlands)
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Cancer Biomarkers Product Type, Application and Specification
10.5.2.1 Type I
10.5.2.2 Type II
10.5.3 Qiagen NV (Netherlands) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main Business/Business Overview
10.6 Agilent Technologies (U.S.)
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Cancer Biomarkers Product Type, Application and Specification
10.6.2.1 Type I
10.6.2.2 Type II
10.6.3 Agilent Technologies (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main Business/Business Overview
10.7 Thermo Fisher Scientific Inc. (U.S.)
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Cancer Biomarkers Product Type, Application and Specification
10.7.2.1 Type I
10.7.2.2 Type II
10.7.3 Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main Business/Business Overview
10.8 Merck & Co. Inc. (U.S.)
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Cancer Biomarkers Product Type, Application and Specification
10.8.2.1 Type I
10.8.2.2 Type II
10.8.3 Merck & Co. Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main Business/Business Overview
10.9 Becton Dickinson and Company (U.S.)
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Cancer Biomarkers Product Type, Application and Specification
10.9.2.1 Type I
10.9.2.2 Type II
10.9.3 Becton Dickinson and Company (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main Business/Business Overview
10.10 Hologic Inc. (U.S.)
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Cancer Biomarkers Product Type, Application and Specification
10.10.2.1 Type I
10.10.2.2 Type II
10.10.3 Hologic Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main Business/Business Overview
11 Cancer Biomarkers Manufacturing Cost Analysis
11.1 Cancer Biomarkers Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Cancer Biomarkers
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Cancer Biomarkers Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List
14 Europe Cancer Biomarkers Market Forecast (2016-2021)
14.1 Germany Cancer Biomarkers Sales Forecast (2016-2021)
14.2 France Cancer Biomarkers Sales Forecast (2016-2021)
14.3 UK Cancer Biomarkers Sales Forecast (2016-2021)
14.4 Russia Cancer Biomarkers Sales Forecast (2016-2021)
14.5 Italy Cancer Biomarkers Sales Forecast (2016-2021)
14.6 Spain Cancer Biomarkers Sales Forecast (2016-2021)
14.7 Benelux Cancer Biomarkers Sales Forecast (2016-2021)
14.8 Europe Cancer Biomarkers Sales Forecast by Type (2016-2021)
14.9 Europe Cancer Biomarkers Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Cancer Biomarkers
Table Classification of Cancer Biomarkers
Figure Europe Sales Market Share of Cancer Biomarkers by Type in 2015
Figure Protein Biomarkers Picture
Figure Genetic Biomarkers Picture
Figure Others Picture
Table Application of Cancer Biomarkers
Figure Europe Sales Market Share of Cancer Biomarkers by Application in 2015
Figure Diagnostics Examples
Figure Drug Discovery and Development Examples
Figure Prognostics Examples
Figure Risk Assessment Examples
Figure Others? Examples
Figure Germany Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure France Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure UK Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure Russia Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure Italy Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure Spain Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure Benelux Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Figure Europe Cancer Biomarkers Sales and Growth Rate (2011-2021)
Figure Europe Cancer Biomarkers Revenue and Growth Rate (2011-2021)
Table Europe Cancer Biomarkers Sales of Key Manufacturers (2015 and 2016)
Table Europe Cancer Biomarkers Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cancer Biomarkers Sales Share by Manufacturers
Figure 2016 Cancer Biomarkers Sales Share by Manufacturers
Table Europe Cancer Biomarkers Revenue by Manufacturers (2015 and 2016)
Table Europe Cancer Biomarkers Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Cancer Biomarkers Revenue Share by Manufacturers
Table 2016 Europe Cancer Biomarkers Revenue Share by Manufacturers
Table Europe Cancer Biomarkers Sales and Market Share by Type (2011-2016)
Table Europe Cancer Biomarkers Sales Share by Type (2011-2016)
Figure Sales Market Share of Cancer Biomarkers by Type (2011-2016)
Figure Europe Cancer Biomarkers Sales Growth Rate by Type (2011-2016)
Table Europe Cancer Biomarkers Revenue and Market Share by Type (2011-2016)
Table Europe Cancer Biomarkers Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Cancer Biomarkers by Type (2011-2016)
Figure Europe Cancer Biomarkers Revenue Growth Rate by Type (2011-2016)
Table Europe Cancer Biomarkers Sales and Market Share by Countries (2011-2016)
Table Europe Cancer Biomarkers Sales Share by Countries (2011-2016)
Figure Sales Market Share of Cancer Biomarkers by Countries (2011-2016)
Table Europe Cancer Biomarkers Revenue and Market Share by Countries (2011-2016)
Table Europe Cancer Biomarkers Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Cancer Biomarkers by Countries (2011-2016)
Table Europe Cancer Biomarkers Sales and Market Share by Application (2011-2016)
Table Europe Cancer Biomarkers Sales Share by Application (2011-2016)
Figure Sales Market Share of Cancer Biomarkers by Application (2011-2016)
Figure Germany Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure Germany Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure Germany Cancer Biomarkers Sales Price Trend (2011-2016)
Table Germany Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Germany Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Germany Cancer Biomarkers Sales by Type (2015 and 2016)
Table Germany Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Germany Cancer Biomarkers Sales by Application (2015 and 2016)
Table Germany Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure France Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure France Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure France Cancer Biomarkers Sales Price Trend (2011-2016)
Table France Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table France Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table France Cancer Biomarkers Sales by Type (2015 and 2016)
Table France Cancer Biomarkers Market Share by Type (2015 and 2016)
Table France Cancer Biomarkers Sales by Application (2015 and 2016)
Table France Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure UK Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure UK Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure UK Cancer Biomarkers Sales Price Trend (2011-2016)
Table UK Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table UK Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table UK Cancer Biomarkers Sales by Type (2015 and 2016)
Table UK Cancer Biomarkers Market Share by Type (2015 and 2016)
Table UK Cancer Biomarkers Sales by Application (2015 and 2016)
Table UK Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Russia Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure Russia Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure Russia Cancer Biomarkers Sales Price Trend (2011-2016)
Table Russia Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Russia Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Russia Cancer Biomarkers Sales by Type (2015 and 2016)
Table Russia Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Russia Cancer Biomarkers Sales by Application (2015 and 2016)
Table Russia Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Italy Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure Italy Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure Italy Cancer Biomarkers Sales Price Trend (2011-2016)
Table Italy Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Italy Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Italy Cancer Biomarkers Sales by Type (2015 and 2016)
Table Italy Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Italy Cancer Biomarkers Sales by Application (2015 and 2016)
Table Italy Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Spain Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure Spain Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure Spain Cancer Biomarkers Sales Price Trend (2011-2016)
Table Spain Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Spain Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Spain Cancer Biomarkers Sales by Type (2015 and 2016)
Table Spain Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Spain Cancer Biomarkers Sales by Application (2015 and 2016)
Table Spain Cancer Biomarkers Market Share by Application (2015 and 2016)
Figure Benelux Cancer Biomarkers Sales and Growth Rate (2011-2016)
Figure Benelux Cancer Biomarkers Revenue and Growth Rate (2011-2016)
Figure Benelux Cancer Biomarkers Sales Price Trend (2011-2016)
Table Benelux Cancer Biomarkers Sales by Manufacturers (2015 and 2016)
Table Benelux Cancer Biomarkers Market Share by Manufacturers (2015 and 2016)
Table Benelux Cancer Biomarkers Sales by Type (2015 and 2016)
Table Benelux Cancer Biomarkers Market Share by Type (2015 and 2016)
Table Benelux Cancer Biomarkers Sales by Application (2015 and 2016)
Table Benelux Cancer Biomarkers Market Share by Application (2015 and 2016)
Table Cancer Biomarkers Basic Information List
Table Abbott Laboratories (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Affymetrix Inc. (U.S.) Basic Information List
Table Affymetrix Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Affymetrix Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Roche Diagnostics Ltd. (Switzerland) Basic Information List
Table Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Diagnostics Ltd. (Switzerland) Cancer Biomarkers Sales Market Share (2011-2016)
Table Illumina, Inc. (U.S.) Basic Information List
Table Illumina, Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Illumina, Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Qiagen NV (Netherlands) Basic Information List
Table Qiagen NV (Netherlands) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Qiagen NV (Netherlands) Cancer Biomarkers Sales Market Share (2011-2016)
Table Agilent Technologies (U.S.) Basic Information List
Table Agilent Technologies (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Agilent Technologies (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Thermo Fisher Scientific Inc. (U.S.) Basic Information List
Table Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Thermo Fisher Scientific Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Merck & Co. Inc. (U.S.) Basic Information List
Table Merck & Co. Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Becton Dickinson and Company (U.S.) Basic Information List
Table Becton Dickinson and Company (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Becton Dickinson and Company (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Hologic Inc. (U.S.) Basic Information List
Table Hologic Inc. (U.S.) Cancer Biomarkers Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hologic Inc. (U.S.) Cancer Biomarkers Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cancer Biomarkers
Figure Manufacturing Process Analysis of Cancer Biomarkers
Figure Cancer Biomarkers Industrial Chain Analysis
Table Raw Materials Sources of Cancer Biomarkers Major Manufacturers in 2015
Table Major Buyers of Cancer Biomarkers
Table Distributors/Traders List
Figure Germany Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure Germany Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure France Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure France Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure UK Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure UK Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure Russia Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure Italy Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure Spain Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Cancer Biomarkers Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Cancer Biomarkers Revenue and Growth Rate Forecast (2016-2021)
Table Europe Cancer Biomarkers Sales Forecast by Type (2016-2021)
Table Europe Cancer Biomarkers Sales Forecast by Application (2016-2021)
  • Global Biomarker Market Research Report 2016
    Published: 30-Nov-2016        Price: US 2900 Onwards        Pages: 115
    Notes: Production, means the output of Biomarker Revenue, means the sales value of Biomarker This report studies Biomarker in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Roche - Merck - Merck - BD - Abbott - Genesys Biolabs(20/20GeneSystems) - ......
  • United States Cancer Biomarkers Market Report 2016
    Published: 25-Oct-2016        Price: US 3800 Onwards        Pages: 120
    Notes: Sales, means the sales volume of Cancer Biomarkers Revenue, means the sales value of Cancer Biomarkers This report studies sales (consumption) of Cancer Biomarkers in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Abbott Laboratories (U.S.) - Affymetrix Inc. (U.S.) - Roche Diagnostics Ltd. (Switzerland) - Illumina, Inc. (U.S.) - Qiagen NV (Netherlands)......
  • China Cancer Biomarkers Market Research Report 2016
    Published: 25-Oct-2016        Price: US 3200 Onwards        Pages: 116
    Notes: Sales, means the sales volume of Cancer Biomarkers Revenue, means the sales value of Cancer Biomarkers This report studies Cancer Biomarkers in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering - Abbott Laboratories (U.S.) - Affymetrix Inc. (U.S.) - Roche Diagnostics Ltd. (Switzerland) - Illumina, Inc. (U.S.) - Qiagen NV (Nether......
  • Global Cancer Biomarkers Market Research Report 2016
    Published: 24-Oct-2016        Price: US 2900 Onwards        Pages: 106
    Notes: Production, means the output of Cancer Biomarkers Revenue, means the sales value of Cancer Biomarkers This report studies Cancer Biomarkers in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Abbott Laboratories (U.S.) - Affymetrix Inc. (U.S.) - Roche Diagnostics Ltd. (......
  • Global Biomarker Partnering Terms and Agreements 2010-2016: Deal trends, players and financials
    Published: 01-Oct-2016        Price: US 2995 Onwards        Pages: 658
    "Delivery of this report will take 1-3 days after purchase." The Global Biomarker Partnering Terms and Agreements 2010-2016: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in biomarker partnering deals Biomarker partnering agreement structure Biomarker partnering cont......
  • Global Neurological Biomarkers Market 2016-2020
    Published: 08-Sep-2016        Price: US 2500 Onwards        Pages: 68
    Biomarkers are the indicators considered for identifying specific diseases. They are mainly used for identification of the progress of a particular disease and evaluation of an effective method for drug target identification. The biomarkers specifically involved in the identification of the neurological disorders are called neurological biomarkers. The analysts forecast global neurological biomarkers market to grow at a CAGR of 15.48% during the period 2016-2020. Cover......
  • Global Circulating Biomarker Sales Market Report 2021
    Published: 12-Aug-2016        Price: US 4000 Onwards        Pages: 129
    This report studies sales (consumption) of Circulating Biomarker in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - BIOCEPT, INC. - QIAGEN - HOFFMANN-LA ROCHE AG - BIO-RAD LABORATORIES INC. - MYRIAD GENETICS - JANSSEN DIAGNOSTICS, LLC. - TR0VAGENE INC. - GUARD......
  • United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Industry 2016 Market Research Report
    Published: 11-Aug-2016        Price: US 3800 Onwards        Pages: 130
    The United States Commercializing Biomarkers in Therapeutic and Diagnostic Applications Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Commercializing Biomarkers in Therapeutic and Diagnostic Applications industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Commercializing Biomarkers in Therapeutic and Diagnostic Applications marke......
  • Global Cardiac Markers Sales Market Report 2021
    Published: 09-Aug-2016        Price: US 4000 Onwards        Pages: 126
    This report studies sales (consumption) of Cardiac Markers in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - ROCHE DIAGNOSTICS LIMITED (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD.) - ABBOTT LABORATORIES, INC. - SIEMENS AG - ALERE INC. - JOHNSON & JOHNSON - INSTRUMENTATION LA......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs